G01N 2333/8117
Bovine/basic pancreatic trypsin inhibitor
Official title: Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
G01N2333/8117 (Bovine/basic pancreatic trypsin inhibitor) appears on 18 US grants and 8 published applications in this corpus.
Search patents in G01N- Granted patents
- 18
- Published applications
- 8
- Assignees
- 13
- Inventors
- 34
- Latest grant
- 25 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Blood collection tube, reagent, and method for analyzing blood characteristics using same25 Oct 2022US 11,480,559 B2Fujimori Kogyo Co., Ltd.
- Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy30 Mar 2021US 10,960,048 B2Guard Therapeutics International AB
- Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions8 Jul 2014US 8,771,714 B2MUSC Foundation for Research Development
- Assay22 May 2012US 8,183,056 B2
- Diagnostic method for identifying carriers of the Marburg I variant of factor VII-activating protease (FSAP) on the basis of differential modulation of FSAP activity17 May 2011US 7,943,333 B2Siemens Healthcare Diagnostics Products GmbH
- Blood Collection Tube, Reagent, and Method for Analyzing Blood Characteristics Using Same3 Jan 2019US 2019/0004031 A1Fujimori Kogyo Co., Ltd.
- Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy30 Aug 2018US 2018/0243369 A1A1M Pharma AB
- Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions21 Jan 2010US 2010/0016697 A1MUSC Foundation for Research Developement
- Assay12 Feb 2009US 2009/0042800 A1
- Method and Kit for the Early Detection of Impaired Renal Status25 Oct 2007US 2007/0248989 A1Children's Hospital Medical Center
Most cited
By later US patents
- Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity48US 6,632,678 B2Sienco, Inc. · 2003
- Method and kit for the early detection of impaired renal status37US 7,662,578 B2Children's Hospital Medical Center · 2010
- Method and reagent for determining biologically active heparin in plasma27US 4,234,682 ABoehringer Mannheim GmbH · 1980
- Stabilized thrombin preparation21US 4,409,334 ABoehringer Mannheim GmbH · 1983
- Process and reagent for the determination of the biological activity of heparin in plasma13US 4,409,327 ABoehringer Mannheim GmbH · 1983